Effects of Physiotherapy in the Treatment of Lymphedema After Breast Cancer

Sponsor
University of Vigo (Other)
Overall Status
Recruiting
CT.gov ID
NCT05037708
Collaborator
Asociación Gallega de Linfedema (Other)
40
1
2
7.9
5.1

Study Details

Study Description

Brief Summary

Lymphedema related to breast cancer is one of the main complications after breast cancer treatment. Manual lymphatic drainage appears as a technique which could be applied in the treatment of lymphedema along with other techniques. The aim of this study is to analyze the effects of a physiotherapy program based on manual lymphatic drainage on the treatment of lymphedema after breast cancer, during the stabilization or maintenance phase of complex decongestant therapy. Therefore, a randomized, blinded, crossover clinical trial is suggested to assess the effect of an intensive physiotherapy intervention on the treatment of lymphedema in its maintenance phase, in comparison with a control group without physiotherapy treatment. The cytometry, displaced water volume, thickness of the lymphedema with ultrasound, dynamometry and sensation of heaviness, pain and tension of the upper limb will be evaluated.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Manual lymphatic drainage
  • Procedure: Manual lymphatic drainage
N/A

Detailed Description

Complex decongestant therapy is a set of techniques which seek the treatment of lymphedema in a conservative way as described in the recent international consensus of the International Lymphology Society, published in 2020. Complex decongestant therapy in a first phase aims to reduce cutaneous edema and in a second phase it aims to preserve and optimize the results obtained.

The first phase consists of skin care, manual lymphatic drainage, muscle pumping exercises, and compression techniques, typically applied with multilayer bandages. The second phase consists of compression with low elasticity, skin care exercises, and repeated manual lymphatic drainage as needed.

The frequency and intensity of components of complex decongestant therapy in phase I and II should depend on the clinical findings of edema and the stage of lymphedema and could be adapted to clinical changes. Note that phase II or stabilization represents long-term therapy over many years and in the case of deterioration of edema, phase I of complex decongestant therapy may need to be repeated.

In recent years, there is debate about the efficacy of manual lymphatic drainage. Sometimes it is not prescribed, being replaced by the recommendation of a self-massage. Furthermore, complex decongestant therapy was suggested to be time consuming, expensive and difficult to tolerate, and does not improve lymphatic function.

In contrast, researchers such as Müller et al., in 2018, state that it is a well-tolerated and safe treatment technique, demonstrating benefits in reducing edema. Other research has also shown that manual lymphatic drainage is effective both on a preventive level and as a postoperative rehabilitation treatment, having optimal results when combined with the other elements of complex decongestant therapy.

A recent systematic review published in 2020 highlights the need of more experimental studies on the effectiveness of manual lymphatic drainage on lymphedema. Thus, the

purpose of this study is to analyze the effects of a physiotherapy program based on manual lymphatic drainage in the treatment of lymphedema after breast cancer, during the stabilization or maintenance phase of complex decongestant therapy. Therefore, a double-blind crossover clinical trial is proposed.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Therefore, a randomized, blinded, crossover clinical trial is suggested to assess the effect of an intensive physiotherapy intervention on the treatment of lymphedema in its maintenance phase, in comparison with a control group without physiotherapy treatment.Therefore, a randomized, blinded, crossover clinical trial is suggested to assess the effect of an intensive physiotherapy intervention on the treatment of lymphedema in its maintenance phase, in comparison with a control group without physiotherapy treatment.
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Effects of Physiotherapy in the Maintenance Phase in the Treatment of Lymphedema After Breast Cancer
Actual Study Start Date :
Mar 1, 2022
Anticipated Primary Completion Date :
Jul 1, 2022
Anticipated Study Completion Date :
Oct 27, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group 1

Group 1 receives treatment A for 4 weeks. Afterwards, a period of washing or bleaching should be allowed in order to be sure that the effects of the intervention have disappeared. This period will last 2 months during which the usual treatment for LGA patients will be carried out, which consists of 2 monthly physiotherapy sessions, in this way it is intended that the subjects are in the initial state (as before the start of the first intervention). After this washout period, treatment B was applied to group 1.

Procedure: Manual lymphatic drainage
Subjects are randomly assigned to group 1. Group 1 receives treatment A* for 4 weeks. Afterwards, a period of washing or bleaching should be allowed in order to be sure that the effects of the intervention have disappeared. This period will last 2 months during which the usual treatment for LGA patients will be carried out, which consists of 2 monthly physiotherapy sessions, in this way it is intended that the subjects are in the initial state (as before the start of the first intervention). After this washout period, treatment B** was applied to group 1 for 4 weeks. *Treatment A consists of manual lymphatic drainage. **Treatment B consists of no treatment

Active Comparator: Group 2

Group 2 receives treatment B for 4 weeks. Afterwards, a period of washing or bleaching should be allowed in order to be sure that the effects of the intervention have disappeared. This period will last 2 months during which the usual treatment for LGA patients will be carried out, which consists of 2 monthly physiotherapy sessions, in this way it is intended that the subjects are in the initial state (as before the start of the first intervention). After this washout period, treatment A was applied to group 2 .

Procedure: Manual lymphatic drainage
Subjects are randomly assigned to group 2. Group 2 receives treatment B** for 4 weeks. Afterwards, a period of washing or bleaching should be allowed in order to be sure that the effects of the intervention have disappeared. This period will last 2 months during which the usual treatment for LGA patients will be carried out, which consists of 2 monthly physiotherapy sessions, in this way it is intended that the subjects are in the initial state (as before the start of the first intervention). After this washout period, treatment A* was applied to group 2 for 4 weeks. *Treatment A consists of manual lymphatic drainage. **Treatment B consists of no treatment

Outcome Measures

Primary Outcome Measures

  1. circometry [1 day]

    measurement of upper limb perimeters

  2. circometry [1 month]

    measurement of upper limb perimeters

  3. circometry [3 month]

    measurement of upper limb perimeters

  4. circometry [4 month]

    measurement of upper limb perimeters

  5. Volumetry by water displacement [1 day]

    weight of water extravasated when introducing the upper limb into a container with water

  6. Volumetry by water displacement [1 month]

    weight of water extravasated when introducing the upper limb into a container with water

  7. Volumetry by water displacement [3 month]

    weight of water extravasated when introducing the upper limb into a container with water

  8. Volumetry by water displacement [4 month]

    weight of water extravasated when introducing the upper limb into a container with water

  9. Measurement of edema thickness by ultrasound [1 day]

    measurement of subcutaneous tissue thickness

  10. Measurement of edema thickness by ultrasound [1 month]

    measurement of subcutaneous tissue thickness

  11. Measurement of edema thickness by ultrasound [3 month]

    measurement of subcutaneous tissue thickness

  12. Measurement of edema thickness by ultrasound [4 month]

    measurement of subcutaneous tissue thickness

Secondary Outcome Measures

  1. Assessment of the sensation of heaviness [1 day]

    Visual analogic scale

  2. Assessment of the sensation of heaviness [1 month]

    Visual analogic scale

  3. Assessment of the sensation of heaviness [3 month]

    Visual analogic scale

  4. Assessment of the sensation of heaviness [4 month]

    Visual analogic scale

  5. Assessment of the sensation of pain [1 day]

    Visual analogic scale

  6. Assessment of the sensation of pain [1 month]

    Visual analogic scale

  7. Assessment of the sensation of pain [3 month]

    Visual analogic scale

  8. Assessment of the sensation of pain [4 month]

    Visual analogic scale

  9. Assessment of the sensation of tension in the upper limb [1 day]

    Visual analogic scale

  10. Assessment of the sensation of tension in the upper limb [1 month]

    Visual analogic scale

  11. Assessment of the sensation of tension in the upper limb [3 month]

    Visual analogic scale

  12. Assessment of the sensation of tension in the upper limb [4 month]

    Visual analogic scale

  13. dynamometry [1 day]

    Assessment of muscle grip strength by dynamometry

  14. dynamometry [1 month]

    Assessment of muscle grip strength by dynamometry

  15. dynamometry [3 month]

    Assessment of muscle grip strength by dynamometry

  16. dynamometry [4 month]

    Assessment of muscle grip strength by dynamometry

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Women included in the lymphedema treatment maintenance program through the Galician Lymphedema Association

  • Women with secondary unilateral lymphedema after breast cancer

Exclusion Criteria:
  • Women undergoing chemotherapy or radiotherapy treatment.

  • Severe systemic or neurological disease

Contacts and Locations

Locations

Site City State Country Postal Code
1 Faculty of Physiotherapy Pontevedra Spain 36005

Sponsors and Collaborators

  • University of Vigo
  • Asociación Gallega de Linfedema

Investigators

  • Principal Investigator: Eva M Lantarón_Caeiro, Dra, Physiotherapy Group (FS1) - Faculty of Physiotherapy -University of Vigo

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Eva María Lantarón Caeiro, Principal Investigator, University of Vigo
ClinicalTrials.gov Identifier:
NCT05037708
Other Study ID Numbers:
  • Fisioterapia en Linfedema
First Posted:
Sep 8, 2021
Last Update Posted:
May 19, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Eva María Lantarón Caeiro, Principal Investigator, University of Vigo
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 19, 2022